Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 13 |
GO:0110165 | cellular anatomical entity | 1 | 13 |
Related structures:
AlphaFold database: Q4Q9H9
Term | Name | Level | Count |
---|---|---|---|
GO:0006508 | proteolysis | 4 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 4 |
GO:0004175 | endopeptidase activity | 4 | 3 |
GO:0004252 | serine-type endopeptidase activity | 5 | 3 |
GO:0008233 | peptidase activity | 3 | 4 |
GO:0008236 | serine-type peptidase activity | 4 | 3 |
GO:0016787 | hydrolase activity | 2 | 4 |
GO:0017171 | serine hydrolase activity | 3 | 3 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 4 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 184 | 186 | PF00675 | 0.437 |
CLV_NRD_NRD_1 | 220 | 222 | PF00675 | 0.649 |
CLV_PCSK_KEX2_1 | 155 | 157 | PF00082 | 0.370 |
CLV_PCSK_KEX2_1 | 183 | 185 | PF00082 | 0.400 |
CLV_PCSK_PC1ET2_1 | 155 | 157 | PF00082 | 0.393 |
CLV_PCSK_PC7_1 | 179 | 185 | PF00082 | 0.492 |
CLV_PCSK_SKI1_1 | 221 | 225 | PF00082 | 0.650 |
CLV_PCSK_SKI1_1 | 47 | 51 | PF00082 | 0.526 |
CLV_PCSK_SKI1_1 | 85 | 89 | PF00082 | 0.587 |
DOC_MAPK_gen_1 | 183 | 191 | PF00069 | 0.584 |
DOC_MAPK_MEF2A_6 | 94 | 101 | PF00069 | 0.311 |
DOC_USP7_MATH_1 | 115 | 119 | PF00917 | 0.623 |
DOC_WW_Pin1_4 | 174 | 179 | PF00397 | 0.625 |
LIG_14-3-3_CanoR_1 | 53 | 61 | PF00244 | 0.384 |
LIG_Actin_WH2_2 | 139 | 157 | PF00022 | 0.620 |
LIG_BRCT_BRCA1_1 | 206 | 210 | PF00533 | 0.420 |
LIG_BRCT_BRCA1_1 | 53 | 57 | PF00533 | 0.385 |
LIG_eIF4E_1 | 100 | 106 | PF01652 | 0.414 |
LIG_eIF4E_1 | 139 | 145 | PF01652 | 0.562 |
LIG_eIF4E_1 | 175 | 181 | PF01652 | 0.649 |
LIG_FHA_1 | 139 | 145 | PF00498 | 0.542 |
LIG_FHA_1 | 19 | 25 | PF00498 | 0.414 |
LIG_FHA_1 | 6 | 12 | PF00498 | 0.536 |
LIG_FHA_1 | 69 | 75 | PF00498 | 0.391 |
LIG_FHA_1 | 86 | 92 | PF00498 | 0.365 |
LIG_FHA_2 | 169 | 175 | PF00498 | 0.581 |
LIG_FHA_2 | 211 | 217 | PF00498 | 0.368 |
LIG_LIR_Apic_2 | 173 | 178 | PF02991 | 0.538 |
LIG_LIR_Apic_2 | 55 | 61 | PF02991 | 0.341 |
LIG_LIR_Gen_1 | 107 | 117 | PF02991 | 0.337 |
LIG_LIR_Gen_1 | 203 | 211 | PF02991 | 0.414 |
LIG_LIR_Gen_1 | 3 | 12 | PF02991 | 0.597 |
LIG_LIR_Nem_3 | 107 | 112 | PF02991 | 0.337 |
LIG_LIR_Nem_3 | 171 | 175 | PF02991 | 0.592 |
LIG_LIR_Nem_3 | 203 | 209 | PF02991 | 0.414 |
LIG_LIR_Nem_3 | 21 | 26 | PF02991 | 0.385 |
LIG_LIR_Nem_3 | 3 | 7 | PF02991 | 0.661 |
LIG_MLH1_MIPbox_1 | 207 | 211 | PF16413 | 0.443 |
LIG_Pex14_2 | 109 | 113 | PF04695 | 0.330 |
LIG_PTB_Apo_2 | 190 | 197 | PF02174 | 0.488 |
LIG_REV1ctd_RIR_1 | 208 | 218 | PF16727 | 0.557 |
LIG_SH2_CRK | 139 | 143 | PF00017 | 0.577 |
LIG_SH2_CRK | 206 | 210 | PF00017 | 0.411 |
LIG_SH2_NCK_1 | 4 | 8 | PF00017 | 0.586 |
LIG_SH2_PTP2 | 175 | 178 | PF00017 | 0.554 |
LIG_SH2_SRC | 4 | 7 | PF00017 | 0.641 |
LIG_SH2_STAP1 | 172 | 176 | PF00017 | 0.540 |
LIG_SH2_STAP1 | 206 | 210 | PF00017 | 0.414 |
LIG_SH2_STAT5 | 100 | 103 | PF00017 | 0.414 |
LIG_SH2_STAT5 | 111 | 114 | PF00017 | 0.328 |
LIG_SH2_STAT5 | 150 | 153 | PF00017 | 0.539 |
LIG_SH2_STAT5 | 166 | 169 | PF00017 | 0.474 |
LIG_SH2_STAT5 | 175 | 178 | PF00017 | 0.536 |
LIG_SH2_STAT5 | 66 | 69 | PF00017 | 0.314 |
LIG_SH3_3 | 80 | 86 | PF00018 | 0.381 |
LIG_SUMO_SIM_anti_2 | 141 | 146 | PF11976 | 0.545 |
LIG_SUMO_SIM_par_1 | 34 | 41 | PF11976 | 0.399 |
LIG_TYR_ITIM | 204 | 209 | PF00017 | 0.451 |
LIG_WRC_WIRS_1 | 106 | 111 | PF05994 | 0.328 |
LIG_WW_3 | 227 | 231 | PF00397 | 0.454 |
MOD_CDK_SPK_2 | 174 | 179 | PF00069 | 0.539 |
MOD_CK2_1 | 168 | 174 | PF00069 | 0.473 |
MOD_GlcNHglycan | 54 | 57 | PF01048 | 0.451 |
MOD_GSK3_1 | 115 | 122 | PF00069 | 0.457 |
MOD_GSK3_1 | 14 | 21 | PF00069 | 0.370 |
MOD_GSK3_1 | 200 | 207 | PF00069 | 0.375 |
MOD_N-GLC_1 | 128 | 133 | PF02516 | 0.455 |
MOD_N-GLC_1 | 68 | 73 | PF02516 | 0.513 |
MOD_NEK2_1 | 105 | 110 | PF00069 | 0.343 |
MOD_NEK2_1 | 204 | 209 | PF00069 | 0.328 |
MOD_NEK2_1 | 210 | 215 | PF00069 | 0.437 |
MOD_NEK2_1 | 25 | 30 | PF00069 | 0.520 |
MOD_NEK2_1 | 37 | 42 | PF00069 | 0.374 |
MOD_NEK2_1 | 51 | 56 | PF00069 | 0.368 |
MOD_NEK2_1 | 65 | 70 | PF00069 | 0.375 |
MOD_PIKK_1 | 121 | 127 | PF00454 | 0.488 |
MOD_PKA_2 | 38 | 44 | PF00069 | 0.552 |
MOD_PKA_2 | 52 | 58 | PF00069 | 0.495 |
MOD_Plk_1 | 18 | 24 | PF00069 | 0.414 |
MOD_Plk_1 | 215 | 221 | PF00069 | 0.504 |
MOD_Plk_4 | 140 | 146 | PF00069 | 0.363 |
MOD_Plk_4 | 18 | 24 | PF00069 | 0.385 |
MOD_Plk_4 | 205 | 211 | PF00069 | 0.328 |
MOD_Plk_4 | 7 | 13 | PF00069 | 0.349 |
MOD_ProDKin_1 | 174 | 180 | PF00069 | 0.547 |
TRG_ENDOCYTIC_2 | 139 | 142 | PF00928 | 0.431 |
TRG_ENDOCYTIC_2 | 206 | 209 | PF00928 | 0.411 |
TRG_ENDOCYTIC_2 | 4 | 7 | PF00928 | 0.575 |
TRG_ER_diArg_1 | 183 | 185 | PF00400 | 0.622 |
TRG_ER_diArg_1 | 211 | 214 | PF00400 | 0.480 |
TRG_NES_CRM1_1 | 6 | 19 | PF08389 | 0.440 |
TRG_Pf-PMV_PEXEL_1 | 85 | 89 | PF00026 | 0.417 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3Z5 | Leptomonas seymouri | 78% | 99% |
A0A0S4INS6 | Bodo saltans | 45% | 100% |
A0A1X0NU17 | Trypanosomatidae | 60% | 100% |
A0A3Q8IDK2 | Leishmania donovani | 97% | 100% |
A0A422N342 | Trypanosoma rangeli | 61% | 100% |
A4HEL7 | Leishmania braziliensis | 86% | 100% |
A4I1V0 | Leishmania infantum | 97% | 100% |
C9ZS72 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 56% | 100% |
E9AXZ3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
Q4Q9I2 | Leishmania major | 100% | 100% |
V5B9I6 | Trypanosoma cruzi | 61% | 100% |